AndrewD.LeavittMD

Hematology • San Francisco, CA

Blood Banking & Transfusion Medicine, Clotting Disorder, Hemophilia & Bleeding Disorder

Professor, Laboratory Medicine, UCSF School of Medicine

Join to view full profile

Dr. Leavitt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Leavitt's full profile

Already have an account?

Office
505 Parnassus Ave
San Francisco, CA 94143
Phone+1 415-514-3432

Fax+1 415-514-3433

Education & Training

University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1988 - 1989
University of MichiganResidency, Internal Medicine, 1986 - 1988
University of MichiganInternship, Internal Medicine, 1984 - 1985
Harvard Medical SchoolClass of 1984

Certifications & Licensure

CA State Medical License 1989 - 2025
MI State Medical License 1987 - 1991
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Neural ensembles that encode nocifensive mechanical and heat pain in mouse spinal cord.
Ming-Dong Zhang, Jussi Kupari, Jie Su, Kajsa A Magnusson, Yizhou Hu
Nature Neuroscience. 2025-03-24
Corticosteroid use to mitigate transaminitis-associated decline in FVIII levels following valoctocogene roxaparvovec gene therapy: clinical practice guidance.
Barbara A Konkle, Flora Peyvandi, Graham R Foster, Cedric Hermans, Vincenzo La Mura
Journal of Thrombosis and Haemostasis. 2025-03-14
Decoding functional hematopoietic progenitor cells in the adult human lung.
Catharina Conrad, Melia Magnen, Jessica Tsui, Harrison Jacob Wismer, Mohammad Naser
Blood. 2025-02-27

Abstracts/Posters

Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial
Andrew D. Leavitt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Updated Follow-up of the Alta Study, a Phase 1/2, Open Label, Adaptive, Dose-Ranging Study to Assess the Safety and Tolerability of SB-525 Gene Therapy in Adult Patien...
Andrew D. Leavitt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Direct Oral Anticoagulant Use and Outcomes in Patients with High and Intermediate Risk BCR-ABL-Negative Myeloproliferative Neoplasms
Andrew D. Leavitt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Phlebitis after Parenteral Iron Sucrose Administration in Postpartum Women
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Pfizer’s Gene Therapy for Rare Genetic Bleeding Disorder Succeeds in Late-Stage TrialJuly 24th, 2024
UCSF Treats Man Who Developed Rare Blood Clot After Johnson and Johnson VaccineApril 30th, 2021
Bay Area Patient Is First MAN to Get Blood Clot After J&J VaccinationApril 26th, 2021
Join now to see all

Grant Support

Molecular Mechanisms Of TPO Induced MPL Signaling In MegakaryocytesNational Heart, Lung, And Blood Institute2001–2005
Novel Systems For The Study Of MegakaryocytopoiesisNational Heart, Lung, And Blood Institute1996–2000